The European Parliament rapporteur on the European Union's seventh framework research program (FP7), Jerzy Buzek, wants the inclusion of allergic diseases under the general health thematic research in the future FP7. In the current European Commission proposal for FP7, allergies figure only under the food thematic research.
Allergies result from complex interactions between genes and environment. Allergic diseases have dramatically in-creased since 1950 due to a number of different factors: greater exposure to allergens, pollutants, dietary changes, food-processing techniques, housing architecture and the water supply. Currently, nearly one-third of children are allergic and 30%-50% of them develop asthma.
"Allergies have a huge negative impact on health, quality of life, education and career achievement and thus present a major health economic burden for the EU," said Anthony Frew, president of the Stockholm, Sweden-based European Academy of Allergology and Clinical Immunology, at a debate organized by Dr Buzek recently, in Brussels.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze